IP Library Granted Patent US 10,207,011
Granted Patent B2
US 10,207,011 · App. 14/314,505 · Granted Feb 19, 2019

Methods, systems, and devices for an invertebrate model of traumatic brain injury

Inventors: Barry S. Ganetzky (Madison, WI); David A. Wassarman (Middleton, WI)
Assignee: Wisconsin Alumni Research Foundation
A61K49/0008A61B5/4064A61B5/4848A61D3/00G01N33/5091A61B2503/40A61B2503/42G01N2333/43573G01N2500/00G01N2800/2814
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,207,011
App. No.
14/314,505
Granted
Feb 19, 2019
Kind
B2
Abstract

Described herein are methods, systems, and devices for identifying agents and genetic pathways that modulate the effects of traumatic brain injury (TBI) in invertebrate model systems having a brain, e.g., Drosophila or C. elegans.

Claims (27)

1. A method for assaying a test agent in Drosophila , the method comprising the steps of:

(i) delivering to one or more Drosophila individuals an impact to induce closed-head traumatic brain injury (TBI) wherein the step of delivering the impact comprises the steps of:

(a) providing the one or more unrestrained Drosophila individuals inside one or more walled containers secured to a spring-loaded acceleration assembly having first and second ends and defining a deflectable long axis therebetween, the assembly fixedly secured at the first end to a base, the one or more containers secured to the assembly at the second end, the assembly configured to accelerate the one or more secured walled containers toward a strike surface upon deflection of the assembly on the long axis followed by release; and

(b) deflecting the assembly on the long axis and releasing the deflected assembly, thereby accelerating the one or more secured walled containers toward and into contact with the strike surface, whereby the unrestrained Drosophila individuals in the one or more walled containers impact the one or more walled containers;

(ii) dosing the one or more Drosophila individuals with a test agent before or after the impact; and

(iii) after the impact, assessing in the dosed one or more Drosophila individuals the severity of a phenotype associated with closed-head TBI selected from the group consisting of lethality, an immune response, neurodegeneration, a sleep abnormality, a circadian abnormality, a learning deficit, a memory deficit, a social behavior deficit, a motor behavior deficit, changes in longevity, changes in intestinal barrier permeability, changes in mitochondrial structure and function, changes in gene expression, changes in enzymatic activity, changes in phosphorylation, changes in post-translational modification, changes in metabolite concentration, changes in cell death, changes in neurotransmitter signaling, and changes in microtubule structure.

2. The method of claim 1 , wherein, in step (ii) the dosing is performed before the impact.

3. The method of claim 1 , wherein, in step (ii) the dosing is performed after the impact.

4. The method of claim 1 , wherein the Drosophila individuals are at least 20 days old.

5. The method of claim 1 wherein step (i) comprises delivering the impact to Drosophila individuals from at least two different genetic backgrounds.

6. The method of claim 5 , wherein step (i) comprises delivering the impact to Drosophila individuals from at least ten different genetic backgrounds.

7. The method of claim 1 , wherein the one or more walled containers contact the strike surface at a predetermined velocity between about 0.5 m/s and about 20 m/s.

8. The method of claim 1 , wherein the acceleration assembly accommodates at least two containers, each container comprising Drosophila individuals.

9. The method of claim 1 wherein the test agent is a transgene.

10. The method of claim 9 , wherein the transgene comprises an expression cassette for an RNAi.

11. The method of claim 9 , wherein the transgene comprises an open reading frame encoding at least one polypeptide.

12. The method of claim 11 , wherein the at least one polypeptide is selected from the group consisting of hAPP, hAbeta1-42, a hTau, a hSynuclein, hHuntingtin, a hTDP-43, a hSOD, hLRRK2, a hGSK3β, and a polyQ polypeptide.

13. The method of claim 9 , wherein the transgene provides in the one or more individuals a non-coding RNA.

14. A method for assaying a test agent in Drosophila , the method comprising the steps of:

(i) delivering to one or more Drosophila individuals an impact to induce closed-head traumatic brain injury (TBI), wherein the step of delivering the impact comprises the steps of:

(a) providing the one or more unrestrained Drosophila individuals inside one or more walled containers secured to a spring-loaded acceleration assembly having first and second ends and defining a deflectable long axis therebetween, the assembly fixedly secured at the first end to a base, the one or more containers secured to the assembly at the second end, the assembly configured to accelerate the one or more secured walled containers toward a strike surface upon deflection of the assembly on the long axis followed by release; and

(b) deflecting the assembly on the long axis and releasing the assembly, thereby accelerating the one or more secured walled containers toward and into contact with the strike surface, whereby the unrestrained Drosophila individuals in the one or more walled containers impact the one or more walled containers;

(ii) dosing the one or more individuals with a test agent before or after the impact; and

(iii) after the impact, assessing closed-head TBI-associated lethality in the dosed one or more Drosophila.

15. The method of claim 14 , wherein, in step (ii) the dosing is performed before the impact.

16. The method of claim 14 , wherein, in step (ii) the dosing is performed after the impact.

17. The method of claim 14 , wherein step (i) comprises delivering the impact to Drosophila individuals from at least two different genetic backgrounds.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 8, 2014
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033695/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2014
From: GANETZKY, BARRY; WASSARMAN, DAVID
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 033340/0262 →
Continuity (2)
Provisional Application 61839215 · Jun 25, 2013
Related Publication 20140377183A1 · Dec 25, 2014